David M. Nanus, MD

David M. Nanus, MD

Weill Cornell Medical College

New York City, New York

David M. Nanus, MD, is the Mark W. Pasmantier Professor of Hematology and Medical Oncology in Medicine and the Director of Genitourinary Cancer at New York-Presbyterian Hospital – Weill Cornell Medicine Healthcare System Cancer Program. He is also Associate Director of Clinical Services at the Meyer Cancer Center at Weill Cornell.

Dr. Nanus completed his medical training at Albert Einstein College of Medicine in the Bronx. He then went on to complete a Fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center, and completed research training at the Sloan Kettering Institute in Manhattan. He was a physician-scientist at MSKCC and later joined the full-time faculty of Weill Cornell Medicine, where he serves as Chief of the Division of Hematology and Medical Oncology. He serves as PI in clinical, translational, and basic research in genitourinary malignancies and novel targeted therapies, and has 200+ publications. He has received numerous awards, including membership in the American Society for Clinical Investigation and the Association of American Physicians.

Disclosures:

Talks by David M. Nanus, MD

Standard Treatment for Advanced Prostate Cancer

David M. Nanus, MD, reviews the approvals for and evidence surrounding therapies to treat advanced prostate cancer. He focuses on taxane chemotherapy, androgen deprivation therapy, androgen receptor pathway inhibitors, bone-targeted therapy, and common approaches in tumor immunotherapy.

Read More

Join the GRU Community

- Why Join? -